Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice
International Journal of Molecular Sciences · 11.01.2026 · 27 (2) · 735
DOI: 10.3390/ijms27020735 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.01.2026. Verfasst von Sandra Angélica Rojas-Osornio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Formación Básica Disciplinaria, Academia de Bioquímica Médica II, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexic…. Hauptthemen laut MEDLINE: Benzoxazines, Body Weight, Appetite, Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Mexicano del Seguro Social, DGAPA. Dirección General de Asuntos del Personal Académico,, Dirección General de Asuntos del Personal Académico.
Abstract (Originalsprache)
Antiretroviral drugs are associated with increased body weight and metabolic disorders. Fat gain and insulin resistance are commonly associated with abdominal obesity in people with HIV (PWH). There is currently an open ongoing discussion about how antiretroviral therapy affects body weight and its significance in hunger–satiety circuit alteration. Until now, the impact of the drug on this circuit has not been explored. This study aimed to assess the hormones involved in appetite and satiety regulation in the serum and hypothalamus after efavirenz (EFV) administration in mice. EFV (10 mg/kg) and distilled water (1.5 μL/kg) (control group) were orally administered for 36 days to CD1 mice. Body weight and food intake were determined throughout treatment. At the end of the treatment, the metabolic profile (glucose, triglycerides, cholesterol) was assessed, and leptin, soluble receptor of leptin (sOB-R), and ghrelin were measured in serum; moreover, we evaluated the expression of growth hormone secretagogue receptor 1a (GHS-R1a), neuropeptide Y receptor 1 (NPYR1), and leptin in the hypothalamus, and a sucrose preference test (SPT) was conducted. Outcomes showed an increase in serum ghrelin and the expression of GHS-R1a and NPYR1 receptors in the hypothalamus, coinciding with an increase in appetite and preference for sucrose in mice in the EFV group. Furthermore, serum leptin, sOB-R, and the free leptin index (FLI) showed that hunger is not related to a lack of satiety. Despite increased food intake, a reduction in body weight was observed, and triglyceride and cholesterol levels were increased. According to our findings, mice treated with EFV showed a decrease in body weight, despite increased food intake resulting from appetite stimulation, which is caused by specific compounds, hormones, and neural signals acting on the brain’s hunger centres, primarily in the hypothalamus, promoting eating behaviours. However, further studies are necessary to investigate the mechanisms of EFV’s effects on energy expenditure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Formación Básica Disciplinaria, Academia de Bioquímica Médica II, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Unidad de Investigación Médica en Enfermedades Endocrinas, Hospital de Especialidades, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
- Division de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Laboratorio Central, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
- Departamento de Infectología, Hospital de Infectología del Centro Médico Nacional "La Raza" IMSS, Mexico City 02990, Mexico.
- Unidad Periférica de Investigación Básica y Clínica en Enfermedades Infecciosas, Departamento de Salud Pública, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510…
ORCID-Profile: Sandra Angélica Rojas-Osornio, Minerva Crespo-Ramírez, Vladimir Paredes-Cervantes, Antonio Mata-Marín, José Molina-López, Miguel Pérez de la Mora, Dasiel Borroto-Escuela, Ricardo Martínez-Lara, Emiliano Tesoro-Cruz
Förderung
- Instituto Mexicano del Seguro Social
- DGAPA. Dirección General de Asuntos del Personal Académico,
- Dirección General de Asuntos del Personal Académico
Zitieren
APA
Rojas-Osornio, S. A., Manuel-Apolinar, L., Crespo-Ramírez, M., Paredes-Cervantes, V., Mata-Marín, A., Molina-López, J., Pérez de la Mora, M., Borroto-Escuela, D., Martínez-Lara, R., & Tesoro-Cruz, E. (2026). Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice. International Journal of Molecular Sciences, 27(2), 735. https://doi.org/10.3390/ijms27020735
Vancouver
Rojas-Osornio SA, Manuel-Apolinar L, Crespo-Ramírez M, Paredes-Cervantes V, Mata-Marín A, Molina-López J, et al. Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice. International Journal of Molecular Sciences. 2026;27(2):735. doi:10.3390/ijms27020735
BibTeX
@article{RojasOsornio2026,
author = {Rojas-Osornio, Sandra Angélica and Manuel-Apolinar, Leticia and Crespo-Ramírez, Minerva and Paredes-Cervantes, Vladimir and Mata-Marín, Antonio and Molina-López, José and Pérez de la Mora, Miguel and Borroto-Escuela, Dasiel and Martínez-Lara, Ricardo and Tesoro-Cruz, Emiliano},
title = {Efavirenz Interacts with Hormones Involved in Appetite and Satiety, Affecting Body Weight in Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {2},
pages = {735},
doi = {10.3390/ijms27020735}
}
EUVIMED